Cytotoxicity of fumonisin B1, diethylnitrosamine, and catechol on the SNO esophageal cancer cell line. by Myburg, Rene B et al.
Environmental Health Perspectives • VOLUME 110 | NUMBER 8 | August 2002 813
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Approximately 60–90% of human cancers
are attributable to environmental factors,
particularly chemical carcinogens (1).
Two important groups of carcinogens that
have emerged are the mycotoxins and
N-nitrosamines. 
Fumonisin B1 (FB1) is a mycotoxin pro-
duced by the fungus Fusarium verticillioides,
a ubiquitous soil-borne fungus that fre-
quently contaminates maize and maize prod-
ucts. FB1 is the most abundant and toxic of
the known fumonisins and has been associ-
ated with many animal diseases, including
equine leukoencephalomalacia (2), porcine
pulmonary edema (3), and liver and kidney
tumors in rats (4). The geographic areas
where FB1 occurs in high concentrations
have been associated with high rates of
esophageal cancer (EC) in humans (5).
Although FB1 has been classified by the
International Agency for Research on
Cancer as a type 2B carcinogen (6) and
appears to be an initiator and promotor of
carcinogenesis in rats (7), we have as yet no
convincing evidence that FB1 is a human
carcinogen.
Minute quantities of nitrosamines are
present in cigarette smoke, alcoholic bever-
ages, and certain foods, but their cumulative
effect over several years could play a role in
cancer. N-nitrosamines are precarcinogens,
giving rise to ultimate carcinogens only after
enzymatic activation under acidic conditions
in the stomach (8). A possible correlation
exists between EC and gastrectomy, that is,
alkaline reflux into the esophagus. This
could account for the mechanism by which
ultimate carcinogens of nitrosamines reach
the esophagus.
N-nitrosamines are organ speciﬁc, and in
this regard, asymmetrical nitrosamines (e.g.,
N-nitrosomethylalanine and N-nitrosopiperi-
dine) have a tendency to induce tumors of
the esophagus (1). Mingxin et al. (9) found
that methylbenzylnitrosamine, nitrososarco-
sine ethyl ester, and other secondary amines
induced carcinoma of the esophagus in rats.
Harris et al. (10) reported that cultured
human esophageal cells activated dimethylni-
trosamine into DNA-binding metabolites.
F. verticillioides enhancement of
nitrosamine-induced EC in rats has been
reported by van Rensburg (11). Also,
nitrosamines and their precursors have been
found in foods from a high-EC area of
China (12). These findings suggest that
nitrosamines may play a role in the etiology
of human esophageal carcinogenesis, possi-
bly by acting synergistically with mycotoxins
or other metabolites of F. verticillioides (13).
Excessive exposure to tobacco and alco-
hol has repeatedly been implicated as a prin-
cipal factor in carcinoma of the esophagus
(14,15). Tobacco and tobacco smoke con-
tain many distinct classes of chemical car-
cinogens and cocarcinogens, including the
N-nitrosamines, which are important envi-
ronmental carcinogens. Dietary catechol
(CAT), a constituent of cigarette smoke, was
previously found to be a cocarcinogen with
methyl-N-nitrosamine (MNAN) for induc-
ing esophageal tumors in rats. CAT in
drinking water was not significantly
cocarcinogenic with MNAN, but ethanol
and CAT given in the drinking water was
cocarcinogenic with MNAN and tumori-
genic when given without MNAN (16). The
increased carcinogenicity by MNAN occurs
because ethanol and CAT affect MNAN
metabolism.
The human esophageal carcinoma cell
line SNO was derived from a well-differenti-
ated squamous cell carcinoma (6.5 cm long
and metastatic to the lymph nodes) that was
explanted from patient S.N., a 62-year-old
Zulu male, in July 1972 (17).
There is sufficient evidence of the car-
cinogenicity of FB1 in test animals, but not
enough data to draw deﬁnite conclusions for
humans (18). We undertook this study to
investigate whether FB1 is an etiologic agent
in human esophageal carcinoma, as well as
to review the cytotoxic effect of other etio-
logic factors in this disease. In this study we
evaluated the cytotoxicity of FB1, diethylni-
trosamine (DEN), and CAT on the human
SNO EC cell line.
Materials and Methods
Materials. We purchased all cell culture
media and plasticware from Sterilin
(Durban, South Africa). We obtained
methylthiazol tetrazolium (MTT) salt,
DEN, and CAT from Sigma Chemical
Company (St. Louis, MO, USA) and FB1
from the Programme on Mycotoxins and
Experimental Carcinogenesis (Cape Town,
South Africa). We purchased all solvents
from Merck (Johannesburg, South Africa).
Preparation of toxin stock solutions.
We prepared stock solutions of FB1, DEN,
and CAT by dissolving 0.5 mg of each
toxin in 30 µL ethanol, 170 µL dimethyl
sulfoxide (DMSO), and 4.8 mL complete
culture medium (CCM; minimum essen-
tial medium supplemented with 5% fetal
calf serum, 1% Penstrep fungizone, and
1% L-glutamine), thus yielding a toxin
concentration of 100 µM. The control
stock solution contained ethanol, DMSO,
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Mycotoxins that commonly contaminate staple food grains pose a health hazard to animals and
humans. Fumonisin B1 (FB1), a mycotoxin produced by Fusarium verticillioides, causes equine
leukoencephalomalacia and porcine pulmonary edema and has been implicated in the etiology of
esophageal cancer (EC) in the Transkei, South Africa. Various studies have indicated that
nitrosamines induce EC, and F. verticillioides enhancement of nitrosamine-induced EC in rats has
been reported. Dietary catechol (CAT), a constituent of cigarette smoke, was previously found to
be a cocarcinogen with methyl-N-nitrosamine for inducing esophageal tumors in rats. In the pre-
sent study we therefore investigated the cytotoxic effects of FB1, diethylnitrosamine (DEN), and
CAT on a human esophageal epithelial cell line (SNO) using the methylthiazol tetrazolium assay.
For each treatment, toxin concentrations ranged from 2.165 to 34.64 µM. The results showed
that the cytotoxic response of SNO cells was highest in cells treated with 34.64 µM FB1. SNO
cells treated with DEN + FB1 showed greater cytotoxicity than did cells treated with FB1 alone,
whereas FB1 appeared to inhibit the cytotoxic effect exerted by CAT alone. The results of this
study provide further evidence for the involvement of FB1 in the etiology of esophageal carci-
noma. Key words: catechol, cell culture, diethylnitrosamine, fumonisin B1, methylthiazol tetra-
zolium assay. Environ Health Perspect 110:813–815 (2002). [Online 28 June 2002]
http://ehpnet1.niehs.nih.gov/docs/2002/110p813-815myburg/abstract.htmland CCM. For the cytotoxicity assay, we
used serial dilutions (2.165–34.64 µM)
prepared from the stock solution. 
Preparation of the MTT salt. We dis-
solved MTT salt (5 mg) in 1 mL Hank’s
balanced salt solution (HBSS) to give a con-
centration of 5 mg/mL. We then ﬁltered the
suspension through a 0.45-µm filter and
stored it in the dark at room temperature
until use.
The MTT assay. We determined the
cytotoxic effect of the toxins on SNO cells
using the MTT assay. We washed two con-
fluent monolayers in 75-cm3 culture flasks 
in CCM with HBSS, which we then
trypsinized to detach cells from the ﬂask. We
removed the trypsin and replaced it with 15
mL CCM and gently shook the ﬂasks to dis-
lodge the cells. We assessed cell viability
using trypan blue, determined cell numbers
using a hemocytometer (19), and resus-
pended cells to give a cell count of 4.5 × 106
cells. We aliquoted the cell suspension (100
µL) into each well of two 96-well tissue cul-
ture plates and incubated them at 37°C.
After 24 hr, we replaced the CCM with
100 µL toxin at concentrations ranging
from 2.165 to 34.64 µM, using five repli-
cates for each serial dilution. After a 48-hr
incubation at 37°C, we removed the toxin
and replaced it with 10 µL MTT (5
mg/mL) and 100 µL CCM, and then incu-
bated the mixture for a further 4 hr. We
subsequently removed the supernatant and
aliquoted 100 µL DMSO into each well to
solubilize any resulting formazan crystals.
After 1 hr, we determined the optical den-
sity of the resulting solution spectrophoto-
metrically using a Bio-Rad (Johannesburg,
South Africa) multiwell plate reader at 595
nm and a reference wavelength of 630 nm.
We calculated cell viability from the
absorbance values obtained.
We then statistically analyzed the results
using one-way analysis of variance (ANOVA)
for multiple comparisons and Student’s t-test
and the Mann-Whitney rank sum test for
two-group comparisons. We constructed
graphs to illustrate cell viability after calcula-
tion of the standard deviation. We consid-
ered data comparisons signiﬁcant if p < 0.05.
Results and Discussion
In this study we evaluated the cytotoxic effect
of FB1 and other etiologic agents (DEN and
CAT) on SNO cells using the MTT assay.
We observed minimal cytotoxicity in
SNO cells exposed to FB1 over 48 hr com-
pared with control cells (Figures 1 and 2),
with FB1-treated cells showing a 23% cell
mortality after 48-hr incubation with 34.64
µM FB1 (p < 0.022). The low cytotoxic
response by SNO cells at the concentrations
tested is in agreement with other studies.
Cawood et al. (20) noted a low cytotoxic
response in primary hepatocytes. However,
FB1 has been shown to be cytotoxic to cer-
tain mammalian cell lines (21,22), suggest-
ing that some tissue may accumulate FB1
over time or may be more susceptible to the
cancer-promoting ability of FB1. The effects
of FB1 are chronic, as suggested by the late
age of onset of EC (between 40 and 60
years). FB1 is also poorly absorbed (experi-
ments show that 90% of FB1 is directly
excreted), which explains why FB1 is a slow-
acting carcinogen (23).
Apart from a chronic effect, the low toxic
response over 48 hr by cells treated with FB1
may suggest that FB1 is more effective as a
cancer promoter than an initiator of EC in
humans. This disagrees with studies that show
a toxic effect by FB1 in rat liver and kidney.
The presence of an amino group and the loca-
tion of the hydroxyl on C14/C15 may also play
an important role in both the toxic and can-
cer-initiating activities of FB1. The presence
of the amino group facilitates the conjugation
of FB1 via gluteraldehyde to protein carriers
(24). This would provide a plausible mecha-
nism by which FB1 exerts its mitogenic effect.
Cytotoxicity depends on the ability of a
molecule to bind cellular receptors and/or
penetrate the cell membrane (dependent on
size, structural conformation, and polarity of
the compound). Polarity appears to be an
important determinant in the cytotoxic
behavior of FB1. In general, less polar mole-
cules have higher cytotoxicity (25). FB1 is a
strongly polar compound (26). This explains
the low cytotoxic response observed on treat-
ment with FB1.
Another possibility is that FB1 acts in
synergy with a cocarcinogen that forms part
of the etiology of EC. It therefore appears
that SNO cells are more susceptible to com-
bined treatment with DEN and FB1. One-
way ANOVA revealed a signiﬁcant difference
between treatment with FB1 alone compared
with treatment with DEN + FB1 at 34.64
µM (p < 0.043), 17.32 µM (p < 0.008), 8.66
µM (p < 0.005), and 4.33 µM (p < 0.03). A
cell mortality of 37% occurred upon treat-
ment with DEN + FB1 (34.64 µM). At the
same concentration, we observed only 9%
cell mortality upon treatment with DEN
alone. Figure 1 shows the differences
observed in cell viability after treating SNO
cells with FB1, DEN, and DEN + FB1.
DEN is part of a widely acting group of
potent carcinogens. Nitrosamines are metab-
olized by mixed-function oxidase enzymes to
a chemically active alkylating agent in the rat
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Figure 2. Cell viability of control, FB1-treated, CAT-treated, and CAT+FB1-
treated SNO cells after 48-hr exposure to the toxins. 
Signiﬁcant difference between *control and FB1; #FB1 and CAT + FB1 (p < 0.05, Student’s t-
test and Mann-Whitney rank sum test). 
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Figure 1. Cell viability of control, FB1-treated, DEN-treated, and DEN+FB1-
treated SNO cells after 48-hr exposure to the toxins. 
Signiﬁcant difference between *control and FB1; #FB1 and DEN + FB1 (p < 0.05, Student’s t-
test and Mann-Whitney rank sum test).
2.16 4.33 8.65 17.3 34.6
120
100
80
60
40
20
0
C
e
l
l
 
v
i
a
b
i
l
i
t
y
 
(
%
)
Concentration (µM)
*
* *
*
# #
Control
FB1
DEN
DEN + FB1and possibly in the human esophagus (27).
This reaction produces alkylating intermedi-
ates that can form O6-alkylguanines from
DNA guanine. DNA guanine then pairs with
thymine rather than cytosine. It is thought
that this mispairing produces a mutation that
initiates carcinogenesis (28). In support of
this view, we detected elevated levels of O6-
methylguanine in esophageal DNA extracted
from EC patients in China (29). When
nitrosamines alkylate rat esophageal DNA
and thereby initiate cancer, they are presum-
ably activated by microsomes in the rat
esophagus because the active metabolites do
not travel in the blood from other organs to
the esophagus (24). The same may apply to
nitrosamine induction of EC in humans.
The results suggest that DEN acts in concert
with FB1 and may act as a cancer initiator to
promote the activity of FB1.
The cytotoxicities of FB1, CAT, and
CAT + FB1 are shown in Figure 2. CAT is
cytotoxic to SNO cells, producing 44% cell
mortality at 34.64 µM (p < 0.03). This
agrees with epidemiologic studies that have
clearly demonstrated a strong positive associ-
ation of chronic tobacco smoking with EC
(14). We also observed a significant differ-
ence between FB1 treatment and FB1 + CAT
at 4.33 µM (p < 0.01) and 2.165 µM (p <
0.038). However, we found no significant
differences in cytotoxic activity between
treatment with FB1 alone and FB1 + CAT
(23% and 28% cell death, respectively)
when we assessed the entire range of concen-
trations against each other. When CAT and
FB1 co-occur, there seems to be a stimula-
tion of cell growth or a reduction in mito-
chondrial dehydrogenase activity. The
results of this study suggest that FB1 inhibits
the effect of CAT on the cells, possibly by
reducing binding sites for the toxin.
Conclusions
The results show that FB1 alone is not
overtly cytotoxic in humans, but that it may
act as a promotor or initiator of carcinogene-
sis in synergy with certain cocarcinogens.
Future studies will involve the treatment and
immunolocalization of FB1 in SNO cells,
using light and electron microscopy. In addi-
tion, we know that FB1 alters sphingolipid
metabolism. We will therefore expose SNO
cells to sphinganine and FB1 to determine
the cytotoxic effect on this cell line.
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